Eileen O'Reilly, MD, discusses the potential role of veliparib in pancreatic cancer.
Eileen O'Reilly, M
Advertisement
Articles by Eileen O'Reilly, M
Advertisement
Latest Updated Articles
Dr. O'Reilly on the Potential Role of Veliparib in Pancreatic CancerPublished: April 14th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
3
Multidisciplinary Breast Cancer Experts Outline Proactive Strategies for Managing Treatment-Related Toxicities: With Neil Iyengar, MD; Heather Moore, CPP, PharmD; and Sarah Donahue, MPH, NP
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5